Fact CheckerSign in

NCT07844434Recruiting

AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG

Prospective Observational Comparative Pilot Study to Evaluate Performance of an AI-based Cardiac Disease Analysis Algorithm Using Standard 12-lead ECG and Single-lead ECG Data

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

This pilot study is designed to evaluate the clinical performance and utility of the SmartECG-EF software in patients undergoing evaluations at Inha University Hospital. The primary objective is to assess how effectively the device assists clinicians in evaluating cardiac function and related clinical parameters. The study will prospectively enroll eligible participants to gather real-world clinical data, contributing to enhanced diagnostic accuracy and patient management.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
9 Sept 2026
Start date
10 Nov 2026
Primary completion date
30 Aug 2027
Lead sponsor
Inha University Hospital
NCT number
NCT07844434

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 10 Nov 2026 to the primary completion date, 30 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Subjects with severe tremor, uncooperativity, or skin conditions that make 1-lead ECG measurement difficult
  • Subjects whose additional study measurements would delay standard medical care due to a critical medical condition

Other

  • Subjects deemed inappropriate or unlikely to comply with the study requirements by the investigator
  • Patients with atrial fibrillation or atrial flutter on ECG at the time of examination
  • Patients with pacing rhythm due to a pacemaker
  • Withdrawal of consent or refusal to agree to personal information usage
  • ECG with sub-standard quality (unanalyzable noise, lead disconnection, etc.; note: unanalyzable rate evaluation can be recorded separately)

Who the study is looking for

  • Written informed consent provided voluntarily by the subject
  • Age ≥ 19 years
  • Patients who undergo standard 12-lead ECG measurement during the study period
  • Subjects with sinus rhythm on ECG at the time of examination
  • Subjects available for additional 1-lead ECG measurement during the same visit

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Inha University Hospital
Coordinator of this site? Confirm its status
IncheonSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.